Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2020

Open Access 01-12-2020 | Obesity | Research article

Association of hemoglobin glycation index and its interaction with obesity/family history of hypertension on hypertension risk: a community-based cross-sectional survey

Authors: Jing Mi, Jian Song, Yingying Zhao, Xuesen Wu

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Login to get access

Abstract

Background

Hemoglobin glycation index (HGI) is considered to be a convenient measurable indicator to assess the inter-individual variation of HbA1c. In the present study, we tested the relationship between HGI and risk of hypertension, and further explored the possible interacting influences of HGI with other such factors on hypertension risk among Chinese individuals.

Methods

The eligible subjects were chosen from a community-based cross-sectional survey in China. We collected relevant data and clinical indicators for each participant. HGI was calculated as “measured HbA1c-predicted HbA1c” and divided into four categories according to quartile. The following indicators were used to assess interactive effects: (1) relative excess risk due to interaction (RERI); (2) attributable proportion due to interaction (AP); and (3) synergy index (SI). Statistical analysis was performed using R software.

Results

Specifically, 1777 eligible participants were selected in this cross-sectional survey. There were 433 subjects who were identified to have hypertension (24.4%). A significant increase in the prevalence of hypertension from Q1 to Q4 of HGI was observed (p < 0.001). Multivariable logistic model demonstrated that subjects at the highest HGI group had a substantially increased risk of being hypertensive than subjects in the first quartile of HGI, as indicated by the OR value of 1.87 (95% CI 1.26–2.78). Moreover, a significant interaction between family history of hypertension and HGI on hypertension risk was detected (RERI: 1.36, 95% CI 0.11–2.63; AP: 0.43, 95% CI 0.17–0.69; and SI:2.68, 95% CI 1.10–6.48). The interactive effect between HGI and abdominal obesity was also found to be significant, as estimated by the value of RERI (1.04, 95% CI 0.24–1.85), AP (0.33, 95% CI 0.11–0.56) and SI (1.96, 95% CI 1.01–3.79). However, in the analysis of the interaction between HGI and general obesity, only the AP value (0.28, 95% CI 0.01–0.54) was observed to be significant.

Conclusion

High HGI was independently associated with the risk of hypertension. Moreover, HGI significantly shared interactions with obesity and family history of hypertension that influenced the risk of hypertension.
Literature
1.
go back to reference Lewington S, Lacey B, Clarke R, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med. 2016;176(4):524–32.CrossRef Lewington S, Lacey B, Clarke R, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med. 2016;176(4):524–32.CrossRef
2.
go back to reference Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203–12.CrossRef Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203–12.CrossRef
3.
go back to reference Wang X, Bots ML, Yang F, et al. Prevalence of hypertension in China: a systematic review and meta-regression analysis of trends and regional differences. J Hypertens. 2014;32(10):1919–27.CrossRef Wang X, Bots ML, Yang F, et al. Prevalence of hypertension in China: a systematic review and meta-regression analysis of trends and regional differences. J Hypertens. 2014;32(10):1919–27.CrossRef
4.
go back to reference Cao D, Zhou Z, Si Y, et al. Prevalence and income-related equity in hypertension in rural China from 1991 to 2011: differences between self-reported and tested measures. BMC Health Serv Res. 2019;19(1):437.CrossRefPubMedCentral Cao D, Zhou Z, Si Y, et al. Prevalence and income-related equity in hypertension in rural China from 1991 to 2011: differences between self-reported and tested measures. BMC Health Serv Res. 2019;19(1):437.CrossRefPubMedCentral
5.
go back to reference Redfern A, Peters SAE, Luo R, et al. Sex differences in the awareness, treatment, and control of hypertension in China: a systematic review with meta-analyses. Hypertens Res. 2019;42(2):273–83.CrossRef Redfern A, Peters SAE, Luo R, et al. Sex differences in the awareness, treatment, and control of hypertension in China: a systematic review with meta-analyses. Hypertens Res. 2019;42(2):273–83.CrossRef
7.
go back to reference Chehregosha H, Khamseh ME, Malek M, Hosseinpanah F, Ismail-Beigi F. A view beyond HbA1c: role of continuous glucose monitoring. Diabetes Ther. 2019;10(3):853–63.CrossRefPubMedCentral Chehregosha H, Khamseh ME, Malek M, Hosseinpanah F, Ismail-Beigi F. A view beyond HbA1c: role of continuous glucose monitoring. Diabetes Ther. 2019;10(3):853–63.CrossRefPubMedCentral
8.
go back to reference Wilson DM, Xing D, Cheng J, et al. Persistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial. Diabetes Care. 2011;34:1315–7.CrossRefPubMedCentral Wilson DM, Xing D, Cheng J, et al. Persistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial. Diabetes Care. 2011;34:1315–7.CrossRefPubMedCentral
9.
go back to reference Cohen RM, Smith EP. Frequency of HbA1c discordance in estimating blood glucose control. Curr Opin Clin Nutr Metab Care. 2008;11(4):512–7.CrossRef Cohen RM, Smith EP. Frequency of HbA1c discordance in estimating blood glucose control. Curr Opin Clin Nutr Metab Care. 2008;11(4):512–7.CrossRef
10.
go back to reference Soros AA, Chalew SA, McCarter RJ, et al. Hemoglobin glycation index: a robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients. Pediatr Diabetes. 2010;11(7):455–61.CrossRef Soros AA, Chalew SA, McCarter RJ, et al. Hemoglobin glycation index: a robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients. Pediatr Diabetes. 2010;11(7):455–61.CrossRef
11.
go back to reference Leslie RD, Cohen RM. Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications. J Diabetes Sci Technol. 2009;3(4):635–43.CrossRefPubMedCentral Leslie RD, Cohen RM. Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications. J Diabetes Sci Technol. 2009;3(4):635–43.CrossRefPubMedCentral
12.
go back to reference van Steen SC, Woodward M, Chalmers J, et al. Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia. 2018;61(4):780–9.CrossRefPubMedCentral van Steen SC, Woodward M, Chalmers J, et al. Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia. 2018;61(4):780–9.CrossRefPubMedCentral
13.
go back to reference Lee B, Heo YJ, Lee YA, et al. Association between hemoglobin glycation index and cardiometabolic risk factors in Korean pediatric nondiabetic population. Ann Pediatr Endocrinol Metab. 2018;23(4):196–203.CrossRefPubMedCentral Lee B, Heo YJ, Lee YA, et al. Association between hemoglobin glycation index and cardiometabolic risk factors in Korean pediatric nondiabetic population. Ann Pediatr Endocrinol Metab. 2018;23(4):196–203.CrossRefPubMedCentral
14.
go back to reference Yu C, Zhao H, Pan L, et al. The additive interaction between body mass index and hypertension family history in han and yugur: the China National Health Survey (CNHS). Int J Hypertens. 2019;2019:8268573.CrossRefPubMedCentral Yu C, Zhao H, Pan L, et al. The additive interaction between body mass index and hypertension family history in han and yugur: the China National Health Survey (CNHS). Int J Hypertens. 2019;2019:8268573.CrossRefPubMedCentral
15.
go back to reference Jian S, Su-Mei N, Xue C, et al. Association and interaction between triglyceride-glucose index and obesity on risk of hypertension in middle-aged and elderly adults. Clin Exp Hypertens. 2017;39(8):732–9.CrossRef Jian S, Su-Mei N, Xue C, et al. Association and interaction between triglyceride-glucose index and obesity on risk of hypertension in middle-aged and elderly adults. Clin Exp Hypertens. 2017;39(8):732–9.CrossRef
16.
go back to reference National Health and Family Planning Commission of the People's Republic of China. Adult weight determination in the health industry standard of the People's Republic of China: WS/T428–2013. Beijing: Standard Press, 2013. National Health and Family Planning Commission of the People's Republic of China. Adult weight determination in the health industry standard of the People's Republic of China: WS/T428–2013. Beijing: Standard Press, 2013.
17.
go back to reference Revision Committee of the Guidelines for the Prevention and Treatment of Hypertension in China. The Guidelines for the Prevention and Treatment of Hypertension in China (Revision 2016) [M] Beijing: People Public Health Publishing Company, 2016. Revision Committee of the Guidelines for the Prevention and Treatment of Hypertension in China. The Guidelines for the Prevention and Treatment of Hypertension in China (Revision 2016) [M] Beijing: People Public Health Publishing Company, 2016.
18.
go back to reference Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. Chinese guidelines for the management of hypertension. Chine J Cardiol. 2010;2011(39):579–616. Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. Chinese guidelines for the management of hypertension. Chine J Cardiol. 2010;2011(39):579–616.
19.
go back to reference Andersson T, Alfredsson L, Kallberg H, et al. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20:575–9.CrossRef Andersson T, Alfredsson L, Kallberg H, et al. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20:575–9.CrossRef
20.
go back to reference Knol MJ, VanderWeele TJ, Groenwold RH, et al. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol. 2011;26(6):433–8.CrossRefPubMedCentral Knol MJ, VanderWeele TJ, Groenwold RH, et al. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol. 2011;26(6):433–8.CrossRefPubMedCentral
21.
go back to reference Nayak AU, Singh BM, Dunmore SJ. Potential clinical error arising from use of HbA1c in diabetes: effects of the glycation gap. Endocr Rev. 2019;40(4):988–99.CrossRef Nayak AU, Singh BM, Dunmore SJ. Potential clinical error arising from use of HbA1c in diabetes: effects of the glycation gap. Endocr Rev. 2019;40(4):988–99.CrossRef
22.
go back to reference Nayak AU, Holland MR, Macdonald DR, et al. Evidence for consistency of the glycation gap in diabetes. Diabetes Care. 2011;34(8):1712–6.CrossRefPubMedCentral Nayak AU, Holland MR, Macdonald DR, et al. Evidence for consistency of the glycation gap in diabetes. Diabetes Care. 2011;34(8):1712–6.CrossRefPubMedCentral
23.
go back to reference Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes]. N Engl J Med. 2008, 358(24):2545–59. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes]. N Engl J Med. 2008, 358(24):2545–59.
24.
go back to reference Hempe JM, Liu S, Myers L, et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care. 2015;38(6):1067–74.CrossRefPubMedCentral Hempe JM, Liu S, Myers L, et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care. 2015;38(6):1067–74.CrossRefPubMedCentral
25.
go back to reference Marini MA, Fiorentino TV, Succurro E, et al. Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals. PLoS ONE. 2017;12(4):e0175547.CrossRefPubMedCentral Marini MA, Fiorentino TV, Succurro E, et al. Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals. PLoS ONE. 2017;12(4):e0175547.CrossRefPubMedCentral
26.
go back to reference Kim MK, Jeong JS, Yun JS, et al. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study. J Diabetes Compl. 2018;32(10):906–10.CrossRef Kim MK, Jeong JS, Yun JS, et al. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study. J Diabetes Compl. 2018;32(10):906–10.CrossRef
27.
go back to reference Hempe JM, Gomez R, McCarter RJ Jr, et al. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Compl. 2002;16(5):313–20.CrossRef Hempe JM, Gomez R, McCarter RJ Jr, et al. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Compl. 2002;16(5):313–20.CrossRef
28.
go back to reference Prasad K, Mishra MD. Advanced glycation end products and its receptor play a role in pathophysiology of hypertension? Int J Angiol. 2017;26(1):1–11.CrossRefPubMedCentral Prasad K, Mishra MD. Advanced glycation end products and its receptor play a role in pathophysiology of hypertension? Int J Angiol. 2017;26(1):1–11.CrossRefPubMedCentral
29.
go back to reference Vasdev S, Gill V, Singal P. Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications. Cell Biochem Biophys. 2007;49(1):48–63.CrossRef Vasdev S, Gill V, Singal P. Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications. Cell Biochem Biophys. 2007;49(1):48–63.CrossRef
30.
go back to reference Felipe DL, Hempe JM, Liu S, et al. Skin intrinsic fluorescence is associated with hemoglobin A(1c) and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes. Diabetes Care. 2011;34(8):1816–20.CrossRefPubMedCentral Felipe DL, Hempe JM, Liu S, et al. Skin intrinsic fluorescence is associated with hemoglobin A(1c) and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes. Diabetes Care. 2011;34(8):1816–20.CrossRefPubMedCentral
31.
go back to reference Hirose A, Tanikawa T, Mori H, et al. Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway. FEBS Lett. 2010;584(1):61–6.CrossRef Hirose A, Tanikawa T, Mori H, et al. Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway. FEBS Lett. 2010;584(1):61–6.CrossRef
32.
go back to reference Hofmann B, Adam AC, Jacobs K, et al. Advanced glycation end product associated skin autofluorescence: a mirror of vascular function? Exp Gerontol. 2013;48(1):38–44.CrossRef Hofmann B, Adam AC, Jacobs K, et al. Advanced glycation end product associated skin autofluorescence: a mirror of vascular function? Exp Gerontol. 2013;48(1):38–44.CrossRef
33.
go back to reference McNulty M, Mahmud A, Feely J. Advanced glycation end-products and arterial stiffness in hypertension. Am J Hypertens. 2007;20(3):242–7.CrossRef McNulty M, Mahmud A, Feely J. Advanced glycation end-products and arterial stiffness in hypertension. Am J Hypertens. 2007;20(3):242–7.CrossRef
34.
go back to reference Vasdev S, Ford CA, Parai S, et al. Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertens. 2000;18:567–73.CrossRef Vasdev S, Ford CA, Parai S, et al. Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertens. 2000;18:567–73.CrossRef
35.
go back to reference Calvino J, Cigarran S, Gonzalez-Tabares L, et al. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant. PLoS ONE. 2018;13(8):e0201118.CrossRefPubMedCentral Calvino J, Cigarran S, Gonzalez-Tabares L, et al. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant. PLoS ONE. 2018;13(8):e0201118.CrossRefPubMedCentral
36.
37.
go back to reference Liu S, Hempe JM, McCarter RJ, et al. Association between inflammation and biological variation in hemoglobin A1c in US nondiabetic adults. J Clin Endocrinol Metab. 2015;100(6):2364–71.CrossRefPubMedCentral Liu S, Hempe JM, McCarter RJ, et al. Association between inflammation and biological variation in hemoglobin A1c in US nondiabetic adults. J Clin Endocrinol Metab. 2015;100(6):2364–71.CrossRefPubMedCentral
38.
go back to reference Vlassara H, Cai W, Crandall J, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A. 2002;99(24):15596–601.CrossRefPubMedCentral Vlassara H, Cai W, Crandall J, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A. 2002;99(24):15596–601.CrossRefPubMedCentral
39.
go back to reference Tahara N, Yamagishi S, Matsui T, et al. Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects. Cardiovasc Ther. 2012;30(1):42–8.CrossRef Tahara N, Yamagishi S, Matsui T, et al. Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects. Cardiovasc Ther. 2012;30(1):42–8.CrossRef
40.
go back to reference Cai W, Ramdas M, Zhu L, et al. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc Natl Acad Sci USA. 2012;109(39):15888–93.CrossRef Cai W, Ramdas M, Zhu L, et al. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc Natl Acad Sci USA. 2012;109(39):15888–93.CrossRef
42.
go back to reference Janghorbani M, Aminorroaya A, Amini M. Comparison of Different Obesity Indices for Predicting Incident Hypertension. High Blood Press Cardiovasc Prev. 2017;24(2):157–66.CrossRef Janghorbani M, Aminorroaya A, Amini M. Comparison of Different Obesity Indices for Predicting Incident Hypertension. High Blood Press Cardiovasc Prev. 2017;24(2):157–66.CrossRef
43.
go back to reference Reho JJ, Rahmouni K. Oxidative and inflammatory signals in obesity-associated vascular abnormalities. Clin Sci (Lond). 2017;131(14):1689–700.CrossRef Reho JJ, Rahmouni K. Oxidative and inflammatory signals in obesity-associated vascular abnormalities. Clin Sci (Lond). 2017;131(14):1689–700.CrossRef
44.
go back to reference Ahn CH, Min SH, Lee DH, et al. Hemoglobin glycation index is associated with cardiovascular diseases in people with impaired glucose metabolism. J Clin Endocrinol Metab. 2017;102(8):2905–13.CrossRefPubMedCentral Ahn CH, Min SH, Lee DH, et al. Hemoglobin glycation index is associated with cardiovascular diseases in people with impaired glucose metabolism. J Clin Endocrinol Metab. 2017;102(8):2905–13.CrossRefPubMedCentral
45.
go back to reference Rhee EJ, Cho JH, Kwon H, et al. Association between coronary artery calcification and the hemoglobin glycation index: the kangbuk samsung health study. J Clin Endocrinol Metab. 2017;102(12):4634–41.CrossRef Rhee EJ, Cho JH, Kwon H, et al. Association between coronary artery calcification and the hemoglobin glycation index: the kangbuk samsung health study. J Clin Endocrinol Metab. 2017;102(12):4634–41.CrossRef
46.
go back to reference Cheng PC, Hsu SR, Cheng YC, et al. Relationship between hemoglobin glycation index and extent of coronary heart disease in individuals with type 2 diabetes mellitus: a cross-sectional study. PeerJ. 2017;5:e3875.CrossRefPubMedCentral Cheng PC, Hsu SR, Cheng YC, et al. Relationship between hemoglobin glycation index and extent of coronary heart disease in individuals with type 2 diabetes mellitus: a cross-sectional study. PeerJ. 2017;5:e3875.CrossRefPubMedCentral
47.
go back to reference Pan Y, Jing J, Wang Y, et al. Association of hemoglobin glycation index with outcomes of acute ischemic stroke in type 2 diabetic patients. Neurol Res. 2018;40(7):573–80.CrossRef Pan Y, Jing J, Wang Y, et al. Association of hemoglobin glycation index with outcomes of acute ischemic stroke in type 2 diabetic patients. Neurol Res. 2018;40(7):573–80.CrossRef
48.
go back to reference Hu DS, Zhu SH, Li X, et al. Association between hemoglobin glycation index and NAFLD in Chinese nondiabetic individuals. Can J Gastroenterol Hepatol. 2019;2019:8748459.PubMedCentral Hu DS, Zhu SH, Li X, et al. Association between hemoglobin glycation index and NAFLD in Chinese nondiabetic individuals. Can J Gastroenterol Hepatol. 2019;2019:8748459.PubMedCentral
49.
go back to reference Fiorentino TV, Marini MA, Succurro E, et al. Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction. Oncotarget. 2017a;8(45):79576–86.CrossRefPubMedCentral Fiorentino TV, Marini MA, Succurro E, et al. Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction. Oncotarget. 2017a;8(45):79576–86.CrossRefPubMedCentral
50.
go back to reference Fiorentino TV, Marini MA, Succurro E, et al. Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals. Diabetes Res Clin Pract. 2017b;134:53–61.CrossRef Fiorentino TV, Marini MA, Succurro E, et al. Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals. Diabetes Res Clin Pract. 2017b;134:53–61.CrossRef
51.
go back to reference Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, et al. Differences in A1Cby race and ethnicity among patients with impaired glucose tolerance in the DiabetesPrevention Program. Diabetes Care. 2007;30:2453–7.CrossRefPubMedCentral Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, et al. Differences in A1Cby race and ethnicity among patients with impaired glucose tolerance in the DiabetesPrevention Program. Diabetes Care. 2007;30:2453–7.CrossRefPubMedCentral
52.
go back to reference Wolffenbuttel BH, Herman WH, Gross JL, Dharmalingam M, Jiang HH, Hardin DS. Ethnicdifferences in glycemic markers in patients with type 2 diabetes. Diabetes Care. 2013;36:2931–6.CrossRefPubMedCentral Wolffenbuttel BH, Herman WH, Gross JL, Dharmalingam M, Jiang HH, Hardin DS. Ethnicdifferences in glycemic markers in patients with type 2 diabetes. Diabetes Care. 2013;36:2931–6.CrossRefPubMedCentral
Metadata
Title
Association of hemoglobin glycation index and its interaction with obesity/family history of hypertension on hypertension risk: a community-based cross-sectional survey
Authors
Jing Mi
Jian Song
Yingying Zhao
Xuesen Wu
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01762-0

Other articles of this Issue 1/2020

BMC Cardiovascular Disorders 1/2020 Go to the issue